Disappointment at rimonabant halt

PUB. DATE

November 2008

SOURCE

Independent Nurse;11/3/2008, p4

SOURCE TYPE

Periodical

DOC. TYPE

Article

ABSTRACT

The article reports on clinicians' disappointment on the suspension of the weight-loss drug rimonabant, issued by the European Medicines Agency (EMEA). It is stated that EMEA raised concerns about the risk of psychiatric disorders in patients treated with the drug, and warned no further prescriptions for it should be issued. However, Sanofi-Aventis, manufacturer of rimonabant, said it was complying with EMEA's recommendation.